Both in Electromedical Equipment
Nexalin Technology vs electroCore
Over the past year NXL returned −96.5% and ECOR returned +42.3%; their daily moves had a correlation of 0.03.
NXL −96.5% ECOR +42.3%Growth of $1, one year, split-adjusted
| Metric | NXL | ECOR |
|---|---|---|
| Price | $1.54 | $7.23 |
| Market cap | $1.6M | $65.2M |
| Today | +2.33% | +0.98% |
| 1 month | −71.6% | −28.6% |
| 6 months | −85.7% | +3.4% |
| Year to date | −90.8% | +61.2% |
| 1 year | −96.6% | +43.5% |
| Revenue growth (YoY) | −82.8% | +28.0% |
| Gross margin | 73.2% | 86.5% |
| Net margin | −18412.7% | −32.4% |
| P/E (TTM) | — | — |
| Price / sales | 7.4× | 1.8× |
| Net cash | $1.0M | $3.3M |
| Dividend yield | — | — |
| Volatility (60d) | 1,001.4% | 65.6% |
| Short % of float | 0.0% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).